European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

Adolf E. Schindler; Howard Carp; René Druckmann; Andrea R. Genazzani; Johannes Huber; Jorge Pasqualini; Karl W. Schweppe; Julia Szekeres-Bartho

doi:10.3109/09513590.2015.1017459

European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

Adolf E. Schindler^*, Howard Carp, René Druckmann, Andrea R. Genazzani, Johannes Huber, Jorge Pasqualini, Karl W. Schweppe, Julia Szekeres-Bartho

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

Original language	English
Pages (from-to)	447-449
Number of pages	3
Journal	Gynecological Endocrinology
Volume	31
Issue number	6
DOIs	https://doi.org/10.3109/09513590.2015.1017459
State	Published - 1 Jun 2015
Externally published	Yes

Keywords

Miscarriage
Prevention
Progestogens

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/09513590.2015.1017459

Cite this

@article{a9ea1cc48f084e3aae1e9b3448ad74a0,

title = "European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens",

abstract = "This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.",

keywords = "Miscarriage, Prevention, Progestogens",

author = "Schindler, {Adolf E.} and Howard Carp and Ren{\'e} Druckmann and Genazzani, {Andrea R.} and Johannes Huber and Jorge Pasqualini and Schweppe, {Karl W.} and Julia Szekeres-Bartho",

year = "2015",

month = jun,

day = "1",

doi = "10.3109/09513590.2015.1017459",

language = "אנגלית",

volume = "31",

pages = "447--449",

journal = "Gynecological Endocrinology",

issn = "0951-3590",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

AU - Schindler, Adolf E.

AU - Carp, Howard

AU - Druckmann, René

AU - Genazzani, Andrea R.

AU - Huber, Johannes

AU - Pasqualini, Jorge

AU - Schweppe, Karl W.

AU - Szekeres-Bartho, Julia

PY - 2015/6/1

Y1 - 2015/6/1

N2 - This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

AB - This guideline has been developed based on studied and clinical investigations. Therefore, it appears to be appropriate to use all the available evidence, which are very encouraging, in a summarized form to propose guidelines by a group of European experts in order to give the gynecologists, obstetricians and reproductive medicine specialists have direction with regard to the prevention or treatment of miscarriage for the benefit of the endangered pregnancies. There are a number of statements, opinions and guidelines already published for this topic, which are not entirely in agreement.

KW - Miscarriage

KW - Prevention

KW - Progestogens

UR - http://www.scopus.com/inward/record.url?scp=84938094239&partnerID=8YFLogxK

U2 - 10.3109/09513590.2015.1017459

DO - 10.3109/09513590.2015.1017459

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 25976550

AN - SCOPUS:84938094239

SN - 0951-3590

VL - 31

SP - 447

EP - 449

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

IS - 6

ER -

European Progestin Club Guidelines for prevention and treatment of threatened or recurrent (habitual) miscarriage with progestogens

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this